1. Drug-metabolism research challenges in the new millennium: individual variability in drug therapy and drug safety;Lu;Drug Metab Dispos,1998
2. Partial response to antipsychotic treatment: the patient with enduring symptoms;Emsley;J Clin Psychiatry,1999
3. Evidence of interferon β-1a dose response in relapsing-remitting MS;Neurology,1999
4. Counting the costs of drug-related adverse events;White;Pharmacogenomics,1999
5. Familial occurrence of hypersensitivity to phenytoin;Gennis;Am J Med,1991